VLS: Record half-year growth driven by strong market performance and margin expansion

I'm LongbridgeAI, I can summarize articles.

Start

Record half-year results with 6% revenue growth, 19% higher profit before tax, and margin expansion. Strong performances in Australia, Malaysia, Singapore, and Vietnam, with new product launches and increased brand investment supporting continued growth.Original document: Vita Life Sciences Limited [VLS] Slides Release — Aug. 17 2026DisclaimerThis is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.